Description
Vaniqa (eflornithine hydrochloride) is a prescription medication for the reduction of unwanted facial hair in women. Designed for application to the skin, Vaniqa should only be used on the face and adjacent areas under the chin of affected individuals. Results can be seen as early as 4-8 weeks when used twice a day, at least 8 hours apart. Tested in women of multiple ethnicities.
Vaniqa works by slowing down the growth of facial hair. It works during the growth stage of the hair cycle by interfering with an enzyme in the follicle necessary for the hair to grow.
